INTRODUCTION
============

The level of high-density lipoprotein cholesterol (HDL-C) independently predicts cardiovascular disease.[@B1][@B2][@B3] Previous genome-wide association studies elucidated genes that may directly influence the level of HDL-C, including the gene for cholesterol ester transfer protein (*CETP*, MIM 118470).[@B4][@B5][@B6][@B7][@B8][@B9][@B10] Specifically, previous Swiss and Korean studies show that *CETP* single nucleotide polymorphisms (SNPs) rs6499861, rs6499863, and rs12708980 are associated with HDL-C level.[@B9][@B10][@B11] Another recent study reported that SNP rs6499863 was related to type 2 diabetes and HDL-C.[@B12] Some studies analyzed the association between CETP gene SNP and HDL-C in subjects with other risk factors like obesity.[@B13][@B14] Family history of diabetes (FHD) is also related to lipid levels.[@B15][@B16] In this study, we hypothesized that *CETP* variants would be linked to HDL-C level in Korean populations. To test this hypothesis, we evaluated the association between HDL-C level and the rs6499861 and rs12708980 *CETP* gene SNPs in Korean men and women. The relation was also analyzed considering obesity and FHD.

MATERIALS AND METHODS
=====================

1. Study population {#sec1}
-------------------

Individuals were selected from Severance Hospital in Seoul, South Korea from 1994 to 2012 (n=4,294).[@B10][@B17] Among 4,294 participants, 137 participants with lipid-lowering therapy were eliminated, and other subjects were eliminated due to missing data for rs6499861 SNP. Thus, the final subjects included 4,123 individuals. Among 4,123 subjects, 1,715 subjects were cardiovascular disease (CVD) patients identified by the health insurance reimbursement data from the National Health Insurance Corporation.[@B17] Other 2408 subjects were the healthy subjects.

Other 2,304 participants were chosen in 2008 from the Bundang-gu area in Gyeonggi Province in Korea.[@B10] Among them, 27 subjects with lipid-lowering therapy were eliminated, and other individuals were eliminated because of missing data for rs6499861 SNP. Thus, the final subjects involved 2,263 individuals.

The Institutional Review Board of Human Research at Eulji University approved the protocols for this study (IRB No: EURIB2018-74), and written informed consent was acquired from all participants prior to participation.

2. Data collection {#sec2}
------------------

Demographic characteristics and cigarette smoking status (current smoker, ex-smoker, or never smoked) were obtained using a structured questionnaire.[@B17] Body mass index (BMI) was calculated as an individual\'s weight divided by height squared (kg/m^2^). Serum was isolated from samples of peripheral venous blood after 12 hours of fasting, stored at −70°C, and analyzed for metabolic biomarkers using a Hitachi 7600 analyzer (Hitachi, Ltd., Tokyo, Japan).

3. Genotyping assays {#sec3}
--------------------

*CETP* rs6499861 and rs12708980 genotypes that our previous study reported were obtained using TaqMan probes.[@B10][@B18] For quality control, duplicate genotyping was performed for 1%--2.5% of samples.

4. Statistical analysis {#sec4}
-----------------------

Data were expressed as mean±standard deviation. SNPs were examined for possible effects on HDL-C levels under an additive model in PLINK. Multivariate linear regression models and multiple logistic regression analyses were performed using SAS statistical software, version 9.2 (SAS Institute, Cary, NC, USA). Odds ratios (ORs) were calculated to test the relation between the *CETP* SNP and abnormal HDL-C levels (\<40 mg/dL). The joint effect of obesity on the association of *CETP* SNP with HDL-C levels was also tested. All statistical examinations were two-sided, and the statistical significance was decided as *p*\<0.05.

RESULTS
=======

Most individuals were middle-aged ([Table 1](#T1){ref-type="table"}), 13.8% had a positive FHD, and 38.8% of men and 3.2% of women were current smokers (data not shown).

###### General characteristics of study population
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  Individuals                       Severance               Bundang-gu     
  --------------------------------- ----------------------- -------------- --------------
  No. of patients                   4,123                   2,263          
  Men (%)                           68.0                    54.8           
  Age (yr)                          52.1±10.2               42.8±7.8       
  Waist circumference (cm)          84.0±9.0                80.0±9.5       
  BMI (kg/m^2^)                     24.4±2.9                23.4±3.0       
  Fasting blood sugar (mg/dL)       97.0±22.7               93.6±16.7      
  Systolic blood pressure (mmHg)    121.9±14.6              117.8±14.2     
  Diastolic blood pressure (mmHg)   78.4±10.8               76.7±11.9      
  HDL-C (mg/dL)                     50.9±11.6               52.1±12.7      
  LDL-C (mg/dL)                     117.1±31.7              118.1±30.6     
  Triglycerides (mg/dL)             143.6±97.1              124.3±81.7     
  Smoking status                                                           
                                    Ex-smoker               1,075 (27.9)   490 (21.7)
                                    Current smoker          1,056 (27.4)   528 (23.3)
  HDL-C                                                                    
                                    Normal (≥40 mg/dL)      3,445 (83.6)   1,919 (84.8)
                                    Abnormal (\<40 mg/dL)   678 (16.4)     344 (15.2)
  FHD                                                                      
                                    Negative                3,527 (85.5)   1,970 (87.1)
                                    Positive                596 (14.5)     293 (13.2)

Values are expressed as mean±standard deviation or number (%) not otherwise specified.

BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; FHD, family history of diabetes.

A linear regression model adjusted for age and gender showed that *CETP* rs6499861 and rs12708980 were related to HDL-C level in the Severance dataset but that only rs6499861 was related to HDL-C level in the Bungdang-gu dataset ([Table 2](#T2){ref-type="table"}).

###### Association between *CETP* SNPs and HDL-C level adjusted for age and gender
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  SNP          Position   Severance   Bungdang-gu^\*^                                  
  ------------ ---------- ----------- ----------------- ------------- ------- -------- -------------
  rs6499861    55548996   0.096       −2.044            7.23×10^−7^   0.096   −1.568   8.91×10^−3^
  rs12708980   55569880   0.096       −2.465            1.54×10^−9^   0.103   −0.839   0.143

CETP, cholesterol ester transfer protein; SNP, single nucleotide polymorphism; HDL-C, high-density lipoprotein cholesterol; MAF, minor allele frequency.

^\*^Bundang-gu data were previously reported in Sull et al. (2012).[@B10]

Individuals with the CG/GG genotype of *CETP* rs6499861 were more at risk of having an abnormal HDL-C level than individuals with the CC genotype. This association between genotype and HDL-C was stronger in women compared with men ([Table 3](#T3){ref-type="table"}), in men with a BMI ≥25.69 kg/m^2^ compared with those with a BMI \<25.69 kg/m^2^ ([Table 4](#T4){ref-type="table"}), and in women with a positive FHD compared with those with a negative FHD ([Table 4](#T4){ref-type="table"}). Individuals with the CG/GG genotype and a BMI ≥25.69 kg/m^2^ were more at risk of having an abnormal HDL-C level than those with the CC genotype or a BMI \<25.69 kg/m^2^ although the interaction effect was not significant ([Table 5](#T5){ref-type="table"}).

###### Age-adjusted ORs of low HDL-C^\*^ in the association with the genotypes of *CETP* SNP rs6499861 in the merged dataset (Severance and Bundang-gu, n=6 386)
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  Individuals   Genotype     Normal (≥40 mg/dL) No. (%)   Abnormal (\<40 mg/dL)                      
  ------------- ------------ ---------------------------- ----------------------- ------------------ --
  All           CC           4,425 (82.5)                 781 (76.4)              1.00 (reference)   
  CG/GG         939 (17.5)   241 (23.6)                   1.45 (1.22--1.71)       \<0.0001           
  Men           CC           2,632 (82.3)                 659 (77.6)              1.00 (reference)   
  CG/GG         565 (17.7)   190 (22.4)                   1.33 (1.10--1.61)       0.0029             
  Women         CC           1,793 (82.7)                 122 (70.5)              1.00 (reference)   
  CG/GG         374 (17.3)   51 (29.5)                    1.99 (1.39--2.85)       0.0002             

OR, odds ratio; CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; CETP, cholesterol ester transfer protein; SNP, single nucleotide polymorphism.

^\*^Adjusted for age, gender, and BMI.

###### Age-adjusted ORs of low HDL-C in the association with the genotypes of *CETP* SNP rs6499861 stratified by gender, BMI, and FHD in the merged dataset (Bundang-gu and Severance, n=6,386)
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  Individual   Genotype           Normal (≥40 mg/dL) No. (%)   Abnormal (\<40 mg/dL)                                   
  ------------ ------------------ ---------------------------- ----------------------- ------------ ------------------ --
  Men                                                                                                                  
               BMI\<23.55         CC                           952 (81.2)              131 (76.2)   1.00 (reference)   
  CG/GG        220 (18.8)         41 (23.8)                    1.34 (0.92--1.97)       0.1246                          
               23.55\<BMI≤25.69   CC                           864 (82.7)              242 (80.9)   1.00 (reference)   
  CG/GG        181 (17.3)         57 (19.1)                    1.12 (0.81--1.56)       0.4936                          
               BMI≥25.69          CC                           816 (83.4)              282 (76.4)   1.00 (reference)   
  CG/GG        162 (16.6)         87 (23.6)                    1.55 (1.15--2.07)       0.0037                          
               Negative FHD       CC                           2,286 (82.4)            562 (78.4)   1.00 (reference)   
  CG/GG        490 (17.6)         155 (21.6)                   1.29 (1.05--1.58)       0.0153                          
               Positive FHD       CC                           346 (82.2)              97 (73.5)    1.00 (reference)   
  CG/GG        75 (17.8)          35 (26.5)                    1.66 (1.05--2.64)       0.0301                          
  Women                                                                                                                
               BMI\<21.34         CC                           637 (84.2)              17 (85.0)    1.00 (reference)   
  CG/GG        120 (15.8)         3 (15.0)                     0.98 (0.28--3.42)       0.9752                          
               21.34\<BMI≤23.82   CC                           585 (81.5)              37 (60.7)    1.00 (reference)   
  CG/GG        133 (18.5)         24 (39.3)                    2.89 (1.66--5.02)       0.0002                          
               BMI≥23.82          CC                           571 (82.5)              63 (75.0)    1.00 (reference)   
  CG/GG        121 (17.5)         21 (25.0)                    1.59 (0.93--2.70)       0.0903                          
               Negative FHD       CC                           1,535 (82.9)            112 (73.2)   1.00 (reference)   
  CG/GG        316 (17.1)         41 (26.8)                    1.78 (1.22--2.61)       0.0030                          
               Positive FHD       CC                           258 (81.7)              10 (50.0)    1.00 (reference)   
  CG/GG        58 (18.3)          10 (50.0)                    4.82 (1.86--12.5)       0.0012                          

OR, odds ratio; CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; CETP, cholesterol ester transfer protein; SNP, single nucleotide polymorphism; BMI, body mass index; FHD, family history of diabetes.

###### Age-adjusted ORs for HDL-C depending on *CETP* rs6499861 genotype and BMI in men in the merged dataset (n=4,046)
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  Individuals     Number by genotype   OR (95% CI)                                           
  --------------- -------------------- ------------- ------------------- ------------------- --------
  BMI (kg/m^2^)                                                                              
                  \<25.69              2,203/508     1.00 (reference)    1.19 (0.93--1.52)   0.1781
                  ≥25.69               1,088/247     1.69 (1.41--2.01)   2.61 (1.97--3.47)   

OR, odds ratio; HDL-C, high-density lipoprotein cholesterol; CETP, cholesterol ester transfer protein; BMI, body mass index.

DISCUSSION
==========

In this study of 6,386 Korean individuals, we found that *CETP* rs6499861 and rs12708980 were associated with a lower HDL-C level and that rs6499861 was more strongly associated with HDL-C level in women than in men. In several previous studies, a *CETP* SNP was associated with HDL-C in women but not in men, and *CETP* SNPs related to HDL-C were linked to type 2 diabetes in women only.[@B5][@B12] However, another study reports associations between *CETP* SNP genotypes and low HDL-C in both women (*p*\<0.0001) and men (*p*=0.0368).[@B19]

We also found that *CETP* rs6499861 was associated with a higher HDL-C level in obese individuals. Likewise, a previous study reports that a G mutation at the CETP442 locus is related to a higher HDL-C level in obese Chinese individuals.[@B13] Another study reports a significant interaction between obese vs. lean status and genetic risk score on HDL-C.[@B14] Although we found a combined effect of BMI and *CETP* SNP genotype on abnormal HDL-C level, the interaction was not statistically significant in the multivariate analysis.

In this study, we also found that *CETP* SNP had a stronger association with HDL-C levels in women subjects with positive FHD than that in women subjects with negative FHD. In a South East Asian study, subjects with a positive FHD had higher HDL-C concentration as compared to subjects with no family history.[@B16] In a Japanese study, low-density lipoprotein cholesterol (LDL-C)/HDL-C ratio was independently associated with maternal family history of type 2 diabetes.[@B15] A study found that a high polyunsaturated fatty acid/saturated fatty acid ratio was related to lower insulin sensitivity and the protective effect of PPARG2 Pro12Ala allele was obvious in subjects with family history of type 2 diabetes.[@B20]

In the present study, the association between the SNPs and HDL-C were inconsistent in the Severance data and Bundang-gu data. One of the possible reasons is that the mean age in the Severance data is much higher than the Bundang-gu data. In this study, CETP gene SNP had stronger relation to HDL-C levels in women than in men. It may be due to the different smoking prevalence between men and women. In our study, 38.8% of men participants and 3.2% of women participants were current smokers like the report of Korean national data.[@B21]

A limitation of the present study is that we did not categorize type of diabetes. However, type 2 diabetes is more common in Korea, whereas the incidence of type 1 diabetes is very low.[@B22][@B23] In conclusion, although the genetic associations of lipid levels in Asian people may not be comparable to those in European people, we found that *CETP* SNPs are associated with serum HDL-C level in Korean individuals and that this relationship is most pronounced in obese men and in women with a FHD.
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